-
Presenter Profiles: Glucose Control—Islet Transplantation vs. Intensive Insulin Therapy
Raphael P.H. Meier, MD, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting’s virtual platform through September 5, 2022.
-
Presenter Profiles: Cost Considerations in Adopting Artificial Intelligence—Societal, Health System and Patient Perspectives
Paolo S. Silva, MD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting’s virtual platform through September 5, 2022.
-
Presenter Profiles: SARS-CoV-2 Infection Induces Beta-Cell Transdifferentiation
Shuibing Chen, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting’s virtual platform through September 5, 2022.
-
Outstanding Scientific Achievement Award lecturer reveals new genomic clues, new potential targets in type 2 diabetes
The ADA presented its 2022 National Scientific & Health Care Achievement Awards to a distinguished group of diabetes researchers, clinicians, and educators on Monday, June 6, at the 82nd Scientific Sessions in New Orleans. Anna L. Gloyn, DPhil, received the Outstanding Scientific Achievement Award for her groundbreaking research.
-
Panel provides update on the future of weekly, oral, and interchangeable insulins
A distinguished panel of experts reviewed the latest information on the development of weekly insulins, oral insulins, glucose-sensitive insulin, and the role of biosimilars and interchangeable insulins on Monday, June 6. Michael A. Weiss, MD, PhD, MBA, discussed the development of glucose-sensitive insulin, or “smart insulin,” that can be activated through the use of a…
-
Behavioral therapy and self-monitoring are critical to weight loss, panel says
Four weight loss researchers discussed the value of behavioral therapy, intensive lifestyle interventions, and pharmacotherapy during a Scientific Sessions symposium on Sunday, June 5. “There’s quite a bit of evidence showing that individuals who self-monitor over time generally are the best in terms of maintenance of behaviors and weight,” said Hollie Raynor, PhD, RD, LDN.
-
Panel discusses barriers, potential solutions to bridge diabetes ‘technology gap’ in underserved populations
An expert panel examined several barriers limiting the use of diabetes technology in under-resourced communities at the 82nd Scientific Sessions. “Regardless of their socioeconomic status, everyone deserves access to the right technology at the right time, especially in a chronic condition like diabetes,” said Vivian N. Ayuk, PharmD, CDCES.
-
Educating hospital staff about diabetes care improves patient outcomes
A panel of clinical leaders discussed the importance of educating hospital staff about diabetes management and care during a Scientific Sessions symposium on Monday, June 6. “It really does affect the patient experience when we don’t do an excellent job managing their glycemia, and that’s the point of education,” said Leigh B. Bak, MSN, APRN,…
-
Experts examine disparities in the use of diabetes medications and technologies
Racial, ethnic, and socioeconomic disparities that limit access to diabetes medications and technologies lead to poor glycemic control, diabetic emergencies, and adverse cardiovascular outcomes, according to Sara Jane Cromer, MD, one of three presenters in a symposium on Monday, June 6, that examined disparities in the use of diabetes medications and technologies.
-
Episode 5: Looking Ahead to Tuesday at the 82nd Scientific Sessions
In the final episode of the ADA Meeting News podcast series, Chair of the 82nd Scientific Sessions Meeting Planning Committee Dana Dabelea, MD, PhD, sits down with host Nick Gerik to preview Tuesday’s program and key events taking place outside the session rooms, and discuss on-demand access to session recordings at the meeting.